Funding Round - Mercy BioAnalytics

Funding Round - Mercy BioAnalytics

Investment Firm

Overview

Mercy BioAnalytics is a biotechnology company that aims to improve and save the lives of people through the early detection of cancer.

Announced Date

Jan 29, 2021

Funding Type

Undisclosed

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

1

Investor Name
Participant InvestorThe Perkins Fund

Round Details and Background

Mercy BioAnalytics raised $27277694 on 2021-01-29 in Funding Round

Mercy BioAnalytics is a biotechnology company that aims to improve and save the lives of people through the early detection of cancer.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 29, 2021
Funding Round - Mercy BioAnalytics
1-27.3M
Apr 03, 2023
Series A - Mercy BioAnalytics
8-41.0M

Recent Activity

There is no recent news or activity for this profile.